401 related articles for article (PubMed ID: 21952330)
21. Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain.
Navarro-Illana E; López-Lacort M; Navarro-Illana P; Vilata JJ; Diez-Domingo J
Vaccine; 2017 Jun; 35(25):3342-3346. PubMed ID: 28499554
[TBL] [Abstract][Full Text] [Related]
22. A reduced national incidence of anogenital warts in young Danish men and women after introduction of a national quadrivalent human papillomavirus vaccination programme for young women--an ecological study.
Sandø N; Kofoed K; Zachariae C; Fouchard J
Acta Derm Venereol; 2014 May; 94(3):288-92. PubMed ID: 24150529
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus.
Broomall EM; Reynolds SM; Jacobson RM
Postgrad Med; 2010 Mar; 122(2):121-9. PubMed ID: 20203463
[TBL] [Abstract][Full Text] [Related]
24. Post-licensure monitoring of HPV vaccine in the United States.
Markowitz LE; Hariri S; Unger ER; Saraiya M; Datta SD; Dunne EF
Vaccine; 2010 Jul; 28(30):4731-7. PubMed ID: 20188681
[TBL] [Abstract][Full Text] [Related]
25. The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries.
Kjaer SK; Tran TN; Sparen P; Tryggvadottir L; Munk C; Dasbach E; Liaw KL; Nygård J; Nygård M
J Infect Dis; 2007 Nov; 196(10):1447-54. PubMed ID: 18008222
[TBL] [Abstract][Full Text] [Related]
26. Decline in genital warts diagnoses among young women and young men since the introduction of the bivalent HPV (16/18) vaccination programme in England: an ecological analysis.
Canvin M; Sinka K; Hughes G; Mesher D
Sex Transm Infect; 2017 Mar; 93(2):125-128. PubMed ID: 27365492
[TBL] [Abstract][Full Text] [Related]
27. [Prevalence of human papillomavirus in the pubic hair follicles of healthy men and male patients with genital warts].
Wang YB; Han T; Zhao CX
Zhonghua Nan Ke Xue; 2010 Sep; 16(9):783-5. PubMed ID: 21171259
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus vaccination of males: attitudes and perceptions of physicians who vaccinate females.
Weiss TW; Zimet GD; Rosenthal SL; Brenneman SK; Klein JD
J Adolesc Health; 2010 Jul; 47(1):3-11. PubMed ID: 20547286
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus, genital warts, and vaccines.
Hsueh PR
J Microbiol Immunol Infect; 2009 Apr; 42(2):101-6. PubMed ID: 19597640
[TBL] [Abstract][Full Text] [Related]
30. Trends in genital warts diagnoses in New Zealand five years following the quadrivalent human papillomavirus vaccine introduction.
Oliphant J; Stewart J; Saxton P; Lo M; Perkins N; Ward D
N Z Med J; 2017 Mar; 130(1452):9-16. PubMed ID: 28337036
[TBL] [Abstract][Full Text] [Related]
31. Early impact of Ontario's human papillomavirus (HPV) vaccination program on anogenital warts (AGWs): A population-based assessment.
Guerra FM; Rosella LC; Dunn S; Wilson SE; Chen C; Deeks SL
Vaccine; 2016 Sep; 34(39):4678-4683. PubMed ID: 27527815
[TBL] [Abstract][Full Text] [Related]
32. Significant decline of HPV 6 infection and genital warts despite low HPV vaccination coverage in young women in Germany: a long-term prospective, cohort data analysis.
Denecke A; Iftner T; Iftner A; Riedle S; Ocak M; Luyten A; Üye I; Tunc K; Petry KU
BMC Infect Dis; 2021 Jul; 21(1):634. PubMed ID: 34215215
[TBL] [Abstract][Full Text] [Related]
33. [Quality of life of patients with condyloma].
Mortensen GL; Larsen HK
Ugeskr Laeger; 2008 Nov; 170(47):3858-62. PubMed ID: 19014739
[TBL] [Abstract][Full Text] [Related]
34. The human papillomavirus vaccines.
Ljubojević S
Acta Dermatovenerol Croat; 2006; 14(3):208. PubMed ID: 17010274
[TBL] [Abstract][Full Text] [Related]
35. Updates on human papillomavirus and genital warts and counseling messages from the 2010 Sexually Transmitted Diseases Treatment Guidelines.
Dunne EF; Friedman A; Datta SD; Markowitz LE; Workowski KA
Clin Infect Dis; 2011 Dec; 53 Suppl 3():S143-52. PubMed ID: 22080267
[TBL] [Abstract][Full Text] [Related]
36. Declines in anogenital warts diagnoses since the change in 2012 to use the quadrivalent HPV vaccine in England: data to end 2017.
Checchi M; Mesher D; Mohammed H; Soldan K
Sex Transm Infect; 2019 Aug; 95(5):368-373. PubMed ID: 30723186
[TBL] [Abstract][Full Text] [Related]
37. Estimation of the impact of genital warts on health-related quality of life.
Woodhall S; Ramsey T; Cai C; Crouch S; Jit M; Birks Y; Edmunds WJ; Newton R; Lacey CJ
Sex Transm Infect; 2008 Jun; 84(3):161-6. PubMed ID: 18339658
[TBL] [Abstract][Full Text] [Related]
38. Adolescent and young adult HPV vaccination in Australia: achievements and challenges.
Garland SM; Skinner SR; Brotherton JM
Prev Med; 2011 Oct; 53 Suppl 1():S29-35. PubMed ID: 21962468
[TBL] [Abstract][Full Text] [Related]
39. [Genital warts and HPV vaccination].
Pilka R; Dvorák V; Fait T
Ceska Gynekol; 2011 Dec; 76(6):468-70. PubMed ID: 22312844
[TBL] [Abstract][Full Text] [Related]
40. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.
Garland SM; Hernandez-Avila M; Wheeler CM; Perez G; Harper DM; Leodolter S; Tang GW; Ferris DG; Steben M; Bryan J; Taddeo FJ; Railkar R; Esser MT; Sings HL; Nelson M; Boslego J; Sattler C; Barr E; Koutsky LA;
N Engl J Med; 2007 May; 356(19):1928-43. PubMed ID: 17494926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
